{"id":520999,"date":"2021-08-02T06:03:24","date_gmt":"2021-08-02T10:03:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/"},"modified":"2021-08-02T06:03:24","modified_gmt":"2021-08-02T10:03:24","slug":"ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/","title":{"rendered":"IDEAYA Biosciences to Participate in Panel Discussion at 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">SOUTH SAN FRANCISCO, Calif.<\/span>, <span class=\"xn-chron\">Aug. 2, 2021<\/span> \/PRNewswire\/ &#8212; IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in a panel discussion at the 2021 Wedbush PacGrow Healthcare Virtual Conference on <span class=\"xn-chron\">August 10, 2021<\/span>.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg\" title=\"(PRNewsfoto\/IDEAYA Biosciences, Inc.)\" alt=\"(PRNewsfoto\/IDEAYA Biosciences, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <u>2021 Wedbush PacGrow Healthcare Virtual Conference<br \/><\/u>&#8220;Synthetic Lethal (Weapon)&#8221; panel discussion <span class=\"xn-chron\">Tuesday, August 10, 2021<\/span> at <span class=\"xn-chron\">11:30 am ET<\/span><br \/>Panelists include:<\/p>\n<ul type=\"disc\">\n<li>\n          <span class=\"xn-person\">Michael Dillon<\/span>, Senior Vice President and Chief Scientific Officer, Head of Research, IDEAYA Biosciences <\/li>\n<li>\n          <span class=\"xn-person\">Markus Renschler<\/span>, President and CEO, Cyteir Therapeutics <\/li>\n<li>Vatnak Vat-Ho, CBO, Ryvu Therapeutics <\/li>\n<li>\n          <span class=\"xn-person\">Barbara Weber<\/span>, Chief Executive Officer, Tango Therapeutics<\/li>\n<\/ul>\n<p>A live audio webcast of the event will be available by visiting the &#8220;Investors\/News and Events\/Investor Calendar&#8221; section of the IDEAYA website at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3244181-1&amp;h=1810374419&amp;u=https%3A%2F%2Fir.ideayabio.com%2Fevents&amp;a=https%3A%2F%2Fir.ideayabio.com%2Fevents\" rel=\"nofollow noopener\">https:\/\/ir.ideayabio.com\/events<\/a>.\u00a0 A replay of the webcast will be available for 30 days following the live event.<\/p>\n<p>\n        <b>About IDEAYA Biosciences<\/b>\n      <\/p>\n<p>IDEAYA is a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.\u00a0 IDEAYA&#8217;s approach integrates capabilities in identifying and validating translational biomarkers with drug discovery to select patient populations most likely to benefit from its targeted therapies.\u00a0 IDEAYA is applying its early research and drug discovery capabilities to synthetic lethality \u2013 which represents an emerging class of precision medicine targets.\u00a0 <\/p>\n<p>\n        <b>Forward-Looking Statements<\/b>\n      <\/p>\n<p>This press release contains forward-looking statements, including, but not limited to, statements related to participation in and\/or presentation at certain investor relations events. IDEAYA undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of IDEAYA in general, see IDEAYA&#8217;s Quarterly Report on Form 10-Q filed on <span class=\"xn-chron\">May 10, 2021<\/span> and any current and periodic reports filed with the U.S. Securities and Exchange Commission.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=AQ59568&amp;sd=2021-08-02\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021-301344774.html\">https:\/\/www.prnewswire.com\/news-releases\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021-301344774.html<\/a><\/p>\n<p>SOURCE  IDEAYA Biosciences, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=AQ59568&amp;Transmission_Id=202108020600PR_NEWS_USPR_____AQ59568&amp;DateId=20210802\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire SOUTH SAN FRANCISCO, Calif., Aug. 2, 2021 \/PRNewswire\/ &#8212; IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in a panel discussion at the 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021. 2021 Wedbush PacGrow Healthcare Virtual Conference&#8220;Synthetic Lethal (Weapon)&#8221; panel discussion Tuesday, August 10, 2021 at 11:30 am ETPanelists include: Michael Dillon, Senior Vice President and Chief Scientific Officer, Head of Research, IDEAYA Biosciences Markus Renschler, President and CEO, Cyteir Therapeutics Vatnak Vat-Ho, CBO, Ryvu Therapeutics Barbara Weber, Chief Executive Officer, Tango Therapeutics A live audio webcast of the event will be available by visiting the &#8220;Investors\/News and Events\/Investor Calendar&#8221; &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;IDEAYA Biosciences to Participate in Panel Discussion at 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-520999","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IDEAYA Biosciences to Participate in Panel Discussion at 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IDEAYA Biosciences to Participate in Panel Discussion at 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SOUTH SAN FRANCISCO, Calif., Aug. 2, 2021 \/PRNewswire\/ &#8212; IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in a panel discussion at the 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021. 2021 Wedbush PacGrow Healthcare Virtual Conference&#8220;Synthetic Lethal (Weapon)&#8221; panel discussion Tuesday, August 10, 2021 at 11:30 am ETPanelists include: Michael Dillon, Senior Vice President and Chief Scientific Officer, Head of Research, IDEAYA Biosciences Markus Renschler, President and CEO, Cyteir Therapeutics Vatnak Vat-Ho, CBO, Ryvu Therapeutics Barbara Weber, Chief Executive Officer, Tango Therapeutics A live audio webcast of the event will be available by visiting the &#8220;Investors\/News and Events\/Investor Calendar&#8221; &hellip; Continue reading &quot;IDEAYA Biosciences to Participate in Panel Discussion at 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-02T10:03:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IDEAYA Biosciences to Participate in Panel Discussion at 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021\",\"datePublished\":\"2021-08-02T10:03:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\\\/\"},\"wordCount\":347,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/820568\\\/IDEAYA_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\\\/\",\"name\":\"IDEAYA Biosciences to Participate in Panel Discussion at 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/820568\\\/IDEAYA_Logo.jpg\",\"datePublished\":\"2021-08-02T10:03:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/820568\\\/IDEAYA_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/820568\\\/IDEAYA_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IDEAYA Biosciences to Participate in Panel Discussion at 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IDEAYA Biosciences to Participate in Panel Discussion at 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/","og_locale":"en_US","og_type":"article","og_title":"IDEAYA Biosciences to Participate in Panel Discussion at 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021 - Market Newsdesk","og_description":"PR Newswire SOUTH SAN FRANCISCO, Calif., Aug. 2, 2021 \/PRNewswire\/ &#8212; IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in a panel discussion at the 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021. 2021 Wedbush PacGrow Healthcare Virtual Conference&#8220;Synthetic Lethal (Weapon)&#8221; panel discussion Tuesday, August 10, 2021 at 11:30 am ETPanelists include: Michael Dillon, Senior Vice President and Chief Scientific Officer, Head of Research, IDEAYA Biosciences Markus Renschler, President and CEO, Cyteir Therapeutics Vatnak Vat-Ho, CBO, Ryvu Therapeutics Barbara Weber, Chief Executive Officer, Tango Therapeutics A live audio webcast of the event will be available by visiting the &#8220;Investors\/News and Events\/Investor Calendar&#8221; &hellip; Continue reading \"IDEAYA Biosciences to Participate in Panel Discussion at 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-02T10:03:24+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IDEAYA Biosciences to Participate in Panel Discussion at 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021","datePublished":"2021-08-02T10:03:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/"},"wordCount":347,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/","name":"IDEAYA Biosciences to Participate in Panel Discussion at 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg","datePublished":"2021-08-02T10:03:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-biosciences-to-participate-in-panel-discussion-at-2021-wedbush-pacgrow-healthcare-virtual-conference-on-august-10-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IDEAYA Biosciences to Participate in Panel Discussion at 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/520999","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=520999"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/520999\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=520999"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=520999"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=520999"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}